301 related articles for article (PubMed ID: 22938021)
1. Retrospective analysis of 12 Korean patients with paraneoplastic pemphigus.
Choi Y; Nam KH; Lee JB; Lee JY; Ihm CW; Lee SE; Oh SH; Hashimoto T; Kim SC
J Dermatol; 2012 Dec; 39(12):973-81. PubMed ID: 22938021
[TBL] [Abstract][Full Text] [Related]
2. Classification, clinical manifestations, and immunopathological mechanisms of the epithelial variant of paraneoplastic autoimmune multiorgan syndrome: a reappraisal of paraneoplastic pemphigus.
Nguyen VT; Ndoye A; Bassler KD; Shultz LD; Shields MC; Ruben BS; Webber RJ; Pittelkow MR; Lynch PJ; Grando SA
Arch Dermatol; 2001 Feb; 137(2):193-206. PubMed ID: 11176692
[TBL] [Abstract][Full Text] [Related]
3. A case of paraneoplastic pemphigus associated with Castleman's disease presenting as erosive lichen planus.
Tey HL; Tang MB
Clin Exp Dermatol; 2009 Dec; 34(8):e754-6. PubMed ID: 19663833
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors of paraneoplastic pemphigus.
Leger S; Picard D; Ingen-Housz-Oro S; Arnault JP; Aubin F; Carsuzaa F; Chaumentin G; Chevrant-Breton J; Chosidow O; Crickx B; D'incan M; Dandurand M; Debarbieux S; Delaporte E; Dereure O; Doutre MS; Guillet G; Jullien D; Kupfer I; Lacour JP; Leonard F; Lok C; Machet L; Martin L; Paul C; Pignon JM; Robert C; Thomas L; Weiller PJ; Ferranti V; Gilbert D; Courville P; Houivet E; Benichou J; Joly P
Arch Dermatol; 2012 Oct; 148(10):1165-72. PubMed ID: 22801794
[TBL] [Abstract][Full Text] [Related]
5. Paraneoplastic pemphigus.
Zhu X; Zhang B
J Dermatol; 2007 Aug; 34(8):503-11. PubMed ID: 17683379
[TBL] [Abstract][Full Text] [Related]
6. Paraneoplastic pemphigus.
Yong AA; Tey HL
Australas J Dermatol; 2013 Nov; 54(4):241-50. PubMed ID: 22759072
[TBL] [Abstract][Full Text] [Related]
7. Autoantibody production from a thymoma and a follicular dendritic cell sarcoma associated with paraneoplastic pemphigus.
Wang J; Bu DF; Li T; Zheng R; Zhang BX; Chen XX; Zhu XJ
Br J Dermatol; 2005 Sep; 153(3):558-64. PubMed ID: 16120143
[TBL] [Abstract][Full Text] [Related]
8. Clinical and immunopathological spectrum of paraneoplastic pemphigus.
Zimmermann J; Bahmer F; Rose C; Zillikens D; Schmidt E
J Dtsch Dermatol Ges; 2010 Aug; 8(8):598-606. PubMed ID: 20180886
[TBL] [Abstract][Full Text] [Related]
9. Retroperitoneal Castleman's tumor and paraneoplastic pemphigus: report of a case and review of the literature.
Menenakos C; Braumann C; Hartmann J; Jacobi CA
World J Surg Oncol; 2007 Apr; 5():45. PubMed ID: 17466075
[TBL] [Abstract][Full Text] [Related]
10. Paraneoplastic pemphigus. An autoimmune mucocutaneous disease associated with neoplasia.
Anhalt GJ; Kim SC; Stanley JR; Korman NJ; Jabs DA; Kory M; Izumi H; Ratrie H; Mutasim D; Ariss-Abdo L
N Engl J Med; 1990 Dec; 323(25):1729-35. PubMed ID: 2247105
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of inflammatory infiltrates in lesions of the oral mucosa, skin, and bronchioles in a case of paraneoplastic pemphigus.
Iida K; Yamaguchi F; Hibi K; Tate G; Ohyama B; Numata S; Hashimoto T; Sato M; Uchida T; Sueki H
Eur J Dermatol; 2012; 22(1):154-5. PubMed ID: 22370168
[No Abstract] [Full Text] [Related]
12. Prevalence of myasthenia gravis and associated autoantibodies in paraneoplastic pemphigus and their correlations with symptoms and prognosis.
Wang R; Li J; Wang M; Hao H; Chen X; Li R; Zhu X
Br J Dermatol; 2015 Apr; 172(4):968-75. PubMed ID: 25388377
[TBL] [Abstract][Full Text] [Related]
13. Castleman's tumours and production of autoantibody in paraneoplastic pemphigus.
Wang L; Bu D; Yang Y; Chen X; Zhu X
Lancet; 2004 Feb; 363(9408):525-31. PubMed ID: 14975615
[TBL] [Abstract][Full Text] [Related]
14. Role of autoantibodies against the linker subdomains of envoplakin and periplakin in the pathogenesis of paraneoplastic pemphigus.
Li J; Bu DF; Huang YC; Zhu XJ
Chin Med J (Engl); 2009 Mar; 122(5):486-95. PubMed ID: 19323896
[TBL] [Abstract][Full Text] [Related]
15. Epitopes in the linker subdomain region of envoplakin recognized by autoantibodies in paraneoplastic pemphigus patients.
Zhang B; Zheng R; Wang J; Bu D; Zhu X
J Invest Dermatol; 2006 Apr; 126(4):832-40. PubMed ID: 16470171
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic pemphigus in children and adolescents.
Mimouni D; Anhalt GJ; Lazarova Z; Aho S; Kazerounian S; Kouba DJ; Mascaro JM; Nousari HC
Br J Dermatol; 2002 Oct; 147(4):725-32. PubMed ID: 12366419
[TBL] [Abstract][Full Text] [Related]
17. [Paraneoplastic pemphigus: Retrospective study of a case series].
Fournet M; Roblot P; P Levillain ; Guillet G; Machet L; Misery L
Ann Dermatol Venereol; 2018 Oct; 145(10):564-571. PubMed ID: 30126641
[TBL] [Abstract][Full Text] [Related]
18. Paraneoplastic pemphigus without antidesmoglein 3 or antidesmoglein 1 autoantibodies.
Inaoki M; Kodera M; Fujimoto A; Nousari HC; Anhalt GJ; Takehara K
Br J Dermatol; 2001 Mar; 144(3):610-3. PubMed ID: 11260026
[TBL] [Abstract][Full Text] [Related]
19. Antibody titers to desmogleins 1 and 3 in a patient with paraneoplastic pemphigus associated with follicular dendritic cell sarcoma.
Seishima M; Oda M; Oyama Z; Yoshimura T; Yamazaki F; Aoki T; Nei M; Hashimoto T
Arch Dermatol; 2004 Dec; 140(12):1500-3. PubMed ID: 15611429
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic pemphigus presenting as a lichen planus pemphigoides-like eruption.
Stevens SR; Griffiths CE; Anhalt GJ; Cooper KD
Arch Dermatol; 1993 Jul; 129(7):866-9. PubMed ID: 8323308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
